APA (7th ed.) Citation

Lin, H., Qu, L., Wei, H., Guo, M., Chen, X., Lin, Q., . . . Chen, Y. (2025). Characterization of Bozitinib as a potential therapeutic agent for MET-amplified gastric cancer. Communications Biology, 8(1), 1. https://doi.org/10.1038/s42003-025-07490-5

Chicago Style (17th ed.) Citation

Lin, Hang, Lingzhi Qu, Hudie Wei, Ming Guo, Xiaojuan Chen, Qianmeng Lin, Huajun Zhang, Shuyan Dai, and Yongheng Chen. "Characterization of Bozitinib as a Potential Therapeutic Agent for MET-amplified Gastric Cancer." Communications Biology 8, no. 1 (2025): 1. https://doi.org/10.1038/s42003-025-07490-5.

MLA (9th ed.) Citation

Lin, Hang, et al. "Characterization of Bozitinib as a Potential Therapeutic Agent for MET-amplified Gastric Cancer." Communications Biology, vol. 8, no. 1, 2025, p. 1, https://doi.org/10.1038/s42003-025-07490-5.